Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Past and Future Burden of Inflammatory Bowel Diseases Based on Modeling of Population-based Data.

Coward S, Clement F, Benchimol EI, Bernstein CN, Avina-Zubieta JA, Bitton A, Carroll MW, Hazlewood G, Jacobson K, Jelinski S, Deardon R, Jones JL, Kuenzig ME, Leddin D, McBrien KA, Murthy SK, Nguyen GC, Otley AR, Panaccione R, Rezaie A, Rosenfeld G, Peña-Sánchez JN, Singh H, Targownik LE, Kaplan GG.

Gastroenterology. 2019 Jan 10. pii: S0016-5085(19)30021-6. doi: 10.1053/j.gastro.2019.01.002. [Epub ahead of print]

2.

Inflammatory bowel disease and new-onset psychiatric disorders in pregnancy and post partum: a population-based cohort study.

Vigod SN, Kurdyak P, Brown HK, Nguyen GC, Targownik LE, Seow CH, Kuenzig ME, Benchimol EI.

Gut. 2019 Jan 9. pii: gutjnl-2018-317610. doi: 10.1136/gutjnl-2018-317610. [Epub ahead of print]

PMID:
30630948
3.

Rural and urban disparities in the care of Canadian patients with inflammatory bowel disease: a population-based study.

Benchimol EI, Kuenzig ME, Bernstein CN, Nguyen GC, Guttmann A, Jones JL, Potter BK, Targownik LE, Catley CA, Nugent ZJ, Tanyingoh D, Mojaverian N, Underwood FE, Siddiq S, Otley AR, Bitton A, Carroll MW, deBruyn JC, Dummer TJ, El-Matary W, Griffiths AM, Jacobson K, Leddin D, Lix LM, Mack DR, Murthy SK, Peña-Sánchez JN, Singh H, Kaplan GG; Canadian Gastro-Intestinal Epidemiology Consortium.

Clin Epidemiol. 2018 Nov 8;10:1613-1626. doi: 10.2147/CLEP.S178056. eCollection 2018.

4.

Upfront Combination Therapy, Compared with Monotherapy, for Patients Not Previously Treated with a Biologic Agent Associates With Reduced Risk of Inflammatory Bowel Disease-related Complications in a Population-based Cohort Study.

Targownik LE, Benchimol EI, Bernstein CN, Singh H, Lix ML, Tennakoon A, Leung S, Aviña A, Coward S, Jones J, Kaplan G, Murthy SK, Nguyen GC, Peña-Sánchez JN.

Clin Gastroenterol Hepatol. 2018 Nov 15. pii: S1542-3565(18)31246-1. doi: 10.1016/j.cgh.2018.11.003. [Epub ahead of print]

PMID:
30448599
5.

Trends and Predictors of Clostridium difficile Infection among Children: A Canadian Population-Based Study.

El-Matary W, Nugent Z, Yu BN, Lix LM, Targownik LE, Bernstein CN, Singh H.

J Pediatr. 2018 Nov 15. pii: S0022-3476(18)31548-8. doi: 10.1016/j.jpeds.2018.10.041. [Epub ahead of print]

PMID:
30448272
6.

Living With Inflammatory Bowel Disease: Protocol for a Longitudinal Study of Factors Associated With Symptom Exacerbations.

Witges K, Targownik LE, Haviva C, Walker JR, Graff LA, Sexton KA, Lix L, Sargent M, Vagianos K, Bernstein CN.

JMIR Res Protoc. 2018 Nov 12;7(11):e11317. doi: 10.2196/11317.

7.

Herpes Zoster Infection and Herpes Zoster Vaccination in a Population-Based Sample of Persons With IBD: Is There Still an Unmet Need?

Nugent Z, Singh H, Targownik LE, Bernstein CN.

Inflamm Bowel Dis. 2018 Jul 31. doi: 10.1093/ibd/izy249. [Epub ahead of print]

PMID:
30085137
8.

Association Between IBD Disability and Reduced Work Productivity (Presenteeism): A Population-Based Study in Manitoba, Canada.

Shafer LA, Walker JR, Restall G, Chhibba T, Ivekovic M, Singh H, Targownik LE, Bernstein CN.

Inflamm Bowel Dis. 2019 Jan 10;25(2):352-359. doi: 10.1093/ibd/izy236.

PMID:
29992248
9.

Persistence With Immunomodulator Monotherapy Use And Incidence of Therapeutic Ineffectiveness Among Users of Immunomodulator Monotherapy in IBD.

Targownik LE, Leung S, Lix LM, Singh H, Bernstein CN.

Am J Gastroenterol. 2018 Aug;113(8):1206-1216. doi: 10.1038/s41395-018-0108-6. Epub 2018 Jun 21.

PMID:
29925912
10.

Editorial: let's take a break from studying the PPI-fracture association.

Targownik LE.

Aliment Pharmacol Ther. 2018 Jun;47(11):1543-1544. doi: 10.1111/apt.14640. No abstract available.

PMID:
29878429
11.

Independent Validation of a Self-Report Version of the IBD Disability Index (IBDDI) in a Population-Based Cohort of IBD Patients.

Shafer LA, Walker JR, Chhibba T, Ivekovic M, Singh H, Targownik LE, Peyrin-Biroulet L, Gower-Rousseau C, Sarter H, Bernstein CN.

Inflamm Bowel Dis. 2018 Mar 19;24(4):766-774. doi: 10.1093/ibd/izx063.

PMID:
29554260
12.

Corrigendum: Surgical Rates for Crohn's Disease Are Decreasing: A Population-Based Time Trend Analysis and Validation Study.

Ma C, Moran GW, Benchimol EI, Targownik LE, Heitman SJ, Hubbard JN, Seow CH, Novak KL, Ghosh S, Panaccione R, Kaplan GG.

Am J Gastroenterol. 2018 Feb;113(2):310. doi: 10.1038/ajg.2017.468. Epub 2017 Dec 19.

PMID:
29257148
13.

Editorial: Non-breaking news! High-dose PPIs likely do not cause fractures.

Targownik LE.

Aliment Pharmacol Ther. 2018 Jan;47(1):137. doi: 10.1111/apt.14381. No abstract available.

PMID:
29226411
14.

Reply.

Singh H, Nugent Z, Targownik LE, Bernstein CN.

Gastroenterology. 2018 Jan;154(1):256-257. doi: 10.1053/j.gastro.2017.11.027. Epub 2017 Nov 23. No abstract available.

PMID:
29175040
15.

Surgical Rates for Crohn's Disease are Decreasing: A Population-Based Time Trend Analysis and Validation Study.

Ma C, Moran GW, Benchimol EI, Targownik LE, Heitman SJ, Hubbard JN, Seow CH, Novak KL, Ghosh S, Panaccione R, Kaplan GG.

Am J Gastroenterol. 2017 Dec;112(12):1840-1848. doi: 10.1038/ajg.2017.394. Epub 2017 Oct 31. Erratum in: Am J Gastroenterol. 2017 Dec 19;:.

16.

Corrigendum: Rural and Urban Residence During Early Life Is Associated with a Lower Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study.

Benchimol EI, Kaplan GG, Otley AR, Nguyen GC, Underwood FE, Guttmann A, Jones JL, Potter BK, Catley CA, Nugent ZJ, Cui Y, Tanyingoh D, Mojaverian N, Bitton A, Carroll MW, deBruyn J, Dummer TJB, El-Matary W, Griffiths AM, Jacobson K, Kuenzig ME, Leddin D, Lix LM, Mack DR, Murthy SK, Sánchez JNP, Singh H, Targownik LE, Vutcovici M, Bernstein CN.

Am J Gastroenterol. 2017 Sep;112(9):1485. doi: 10.1038/ajg.2017.271. Epub 2017 Aug 22.

17.

Health Care Services in IBD: Factors Associated with Service Utilization and Preferences for Service Options for Routine and Urgent Care.

Bernstein MT, Walker JR, Chhibba T, Ivekovic M, Singh H, Targownik LE, Bernstein CN.

Inflamm Bowel Dis. 2017 Sep;23(9):1461-1469. doi: 10.1097/MIB.0000000000001215.

PMID:
28816754
18.

Rural and Urban Residence During Early Life is Associated with Risk of Inflammatory Bowel Disease: A Population-Based Inception and Birth Cohort Study

Benchimol EI, Kaplan GG, Otley AR, Nguyen GC, Underwood FE, Guttmann A, Jones JL, Potter BK, Catley CA, Nugent ZJ, Cui Y, Tanyingoh D, Mojaverian N, Bitton A, Carroll MW, deBruyn J, Dummer TJB, El-Matary W, Griffiths AM, Jacobson K, Kuenzig ME, Leddin D, Lix LM, Mack DR, Murthy SK, Sánchez JNP, Singh H, Targownik LE, Vutcovici M, Bernstein CN.

Am J Gastroenterol. 2017 Sep;112(9):1412-1422. doi: 10.1038/ajg.2017.208. Epub 2017 Jul 25. Erratum in: Am J Gastroenterol. 2017 Sep;112(9):1485.

19.

Workplace Accommodation for Persons With IBD: What Is Needed and What Is Accessed.

Chhibba T, Walker JR, Sexton K, Restall G, Ivekovic M, Shafer LA, Singh H, Targownik LE, Bernstein CN.

Clin Gastroenterol Hepatol. 2017 Oct;15(10):1589-1595.e4. doi: 10.1016/j.cgh.2017.05.046. Epub 2017 Jun 8.

PMID:
28603056
20.

Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.

Nguyen GC, Boland K, Afif W, Bressler B, Jones JL, Weizman AV, Fowler S, Halder S, Huang VW, Kaplan GG, Khanna R, Murthy SK, Ruel J, Seow CH, Targownik LE, Chawla T, Guimaraes L, Fernandes A, Saleh S, Melmed GY.

Inflamm Bowel Dis. 2017 Jun;23(6):858-865. doi: 10.1097/MIB.0000000000001152.

PMID:
28509817
21.

Coping with Inflammatory Bowel Disease: Engaging with Information to Inform Health-Related Decision Making in Daily Life.

Restall GJ, Simms AM, Walker JR, Haviva C, Graff LA, Sexton KA, Miller N, Targownik LE, Bernstein CN.

Inflamm Bowel Dis. 2017 Aug;23(8):1247-1256. doi: 10.1097/MIB.0000000000001141.

PMID:
28498156
22.

Higher Incidence of Clostridium difficile Infection Among Individuals With Inflammatory Bowel Disease.

Singh H, Nugent Z, Yu BN, Lix LM, Targownik LE, Bernstein CN.

Gastroenterology. 2017 Aug;153(2):430-438.e2. doi: 10.1053/j.gastro.2017.04.044. Epub 2017 May 4.

PMID:
28479377
23.

Estimates of Disease Course in Inflammatory Bowel Disease Using Administrative Data: A Population-level Study.

Melesse DY, Lix LM, Nugent Z, Targownik LE, Singh H, Blanchard JF, Bernstein CN.

J Crohns Colitis. 2017 May 1;11(5):562-570. doi: 10.1093/ecco-jcc/jjw201.

PMID:
28453762
24.

Trends in Epidemiology of Pediatric Inflammatory Bowel Disease in Canada: Distributed Network Analysis of Multiple Population-Based Provincial Health Administrative Databases.

Benchimol EI, Bernstein CN, Bitton A, Carroll MW, Singh H, Otley AR, Vutcovici M, El-Matary W, Nguyen GC, Griffiths AM, Mack DR, Jacobson K, Mojaverian N, Tanyingoh D, Cui Y, Nugent ZJ, Coulombe J, Targownik LE, Jones JL, Leddin D, Murthy SK, Kaplan GG.

Am J Gastroenterol. 2017 Jul;112(7):1120-1134. doi: 10.1038/ajg.2017.97. Epub 2017 Apr 18.

25.

Temporal Trends in Initiation of Therapy With Tumor Necrosis Factor Antagonists for Patients With Inflammatory Bowel Disease: A Population-based Analysis.

Targownik LE, Tennakoon A, Leung S, Lix LM, Singh H, Bernstein CN.

Clin Gastroenterol Hepatol. 2017 Jul;15(7):1061-1070.e1. doi: 10.1016/j.cgh.2017.01.035. Epub 2017 Feb 24.

PMID:
28238957
26.

Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.

Sexton KA, Walker JR, Graff LA, Bernstein MT, Beatie B, Miller N, Sargent M, Targownik LE.

Inflamm Bowel Dis. 2017 Mar;23(3):473-483. doi: 10.1097/MIB.0000000000001040.

PMID:
28221251
27.

Factors Associated with Discontinuation of Anti-TNF Inhibitors Among Persons with IBD: A Population-Based Analysis.

Targownik LE, Tennakoon A, Leung S, Lix LM, Nugent Z, Singh H, Bernstein CN.

Inflamm Bowel Dis. 2017 Mar;23(3):409-420. doi: 10.1097/MIB.0000000000001025.

PMID:
28221250
28.

Maternal Infections That Would Warrant Antibiotic Use Antepartum or Peripartum Are Not a Risk Factor for the Development of IBD: A Population-Based Analysis.

Bernstein CN, Burchill C, Targownik LE, Singh H, Ghia JE, Roos LL.

Inflamm Bowel Dis. 2017 Apr;23(4):635-640. doi: 10.1097/MIB.0000000000001042.

PMID:
28195851
29.

Predictors of Emergency Department Use by Persons with Inflammatory Bowel Diseases: A Population-based Study.

Nugent Z, Singh H, Targownik LE, Strome T, Snider C, Bernstein CN.

Inflamm Bowel Dis. 2016 Dec;22(12):2907-2916.

PMID:
27846193
30.

Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure.

Targownik LE, Goertzen AL, Luo Y, Leslie WD.

Am J Gastroenterol. 2017 Jan;112(1):95-101. doi: 10.1038/ajg.2016.481. Epub 2016 Nov 15.

PMID:
27845341
31.

Assessing the Relationship between Sources of Stress and Symptom Changes among Persons with IBD over Time: A Prospective Study.

Bernstein MT, Targownik LE, Sexton KA, Graff LA, Miller N, Walker JR.

Can J Gastroenterol Hepatol. 2016;2016:1681507. Epub 2016 Oct 4.

32.

Performance of administrative case definitions for depression and anxiety in inflammatory bowel disease.

Marrie RA, Walker JR, Graff LA, Lix LM, Bolton JM, Nugent Z, Targownik LE, Bernstein CN; CIHR Team “Defining the burden and managing the effects of psychiatric comorbidity in chronic immunoinflammatory disease”.

J Psychosom Res. 2016 Oct;89:107-13. doi: 10.1016/j.jpsychores.2016.08.014. Epub 2016 Sep 3.

PMID:
27663119
33.

Validating a Measure of Patient Self-efficacy in Disease Self-management Using a Population-based IBD Cohort: The IBD Self-efficacy Scale.

Graff LA, Sexton KA, Walker JR, Clara I, Targownik LE, Bernstein CN.

Inflamm Bowel Dis. 2016 Sep;22(9):2165-72. doi: 10.1097/MIB.0000000000000856.

PMID:
27542132
34.

Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.

Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Hu N, Juurlink DN, Paterson JM, Targownik LE, Turin TC, Ernst P; and the Canadian Network for Observational Drug Effect Studies (CNODES) Investigators, Suissa S, Dormuth CR, Hemmelgarn BR, Teare GF, Caetano P, Chateau D, Henry DA, Paterson JM, LeLorier J, Levy AR, Ernst P, Platt RW, Sketris IS.

JAMA Intern Med. 2016 Oct 1;176(10):1464-1473. doi: 10.1001/jamainternmed.2016.1522.

PMID:
27479930
35.

Ustekinumab for the treatment of Crohn's disease.

Hansen T, Targownik LE.

Expert Rev Gastroenterol Hepatol. 2016 Sep;10(9):989-94. doi: 10.1080/17474124.2016.1215912. Epub 2016 Jul 28. Review.

PMID:
27450626
36.

Understanding Work Experiences of People with Inflammatory Bowel Disease.

Restall GJ, Simms AM, Walker JR, Graff LA, Sexton KA, Rogala L, Miller N, Haviva C, Targownik LE, Bernstein CN.

Inflamm Bowel Dis. 2016 Jul;22(7):1688-97. doi: 10.1097/MIB.0000000000000826.

PMID:
27271487
37.

Rates and Reasons for Nonuse of Prescription Medication for Inflammatory Bowel Disease in a Referral Clinic.

Bhasin S, Singh H, Targownik LE, Israeli E, Bernstein CN.

Inflamm Bowel Dis. 2016 Apr;22(4):919-24. doi: 10.1097/MIB.0000000000000753.

PMID:
26933748
38.

A comparison of the gut microbiome between long-term users and non-users of proton pump inhibitors.

Clooney AG, Bernstein CN, Leslie WD, Vagianos K, Sargent M, Laserna-Mendieta EJ, Claesson MJ, Targownik LE.

Aliment Pharmacol Ther. 2016 May;43(9):974-84. doi: 10.1111/apt.13568. Epub 2016 Feb 29.

39.

Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.

Azoulay L, Filion KB, Platt RW, Dahl M, Dormuth CR, Clemens KK, Durand M, Juurlink DN, Targownik LE, Turin TC, Paterson JM, Ernst P; Canadian Network for Observational Drug Effect Studies Investigators.

BMJ. 2016 Feb 17;352:i581. doi: 10.1136/bmj.i581.

40.

Emerging issues in the medical management of Crohn's disease.

Targownik LE, Coneys JG, Dhillon AS.

Curr Opin Gastroenterol. 2016 Mar;32(2):103-9. doi: 10.1097/MOG.0000000000000242. Review.

PMID:
26839964
41.

Failure to Account for Immortal Person Time Likely Accounts for the Apparent Reduction in Surgery Among Natalizumab Users.

Targownik LE.

Clin Gastroenterol Hepatol. 2016 May;14(5):776. doi: 10.1016/j.cgh.2015.11.008. Epub 2015 Nov 22. No abstract available.

PMID:
26614877
42.

Reply: To PMID 26077178.

Targownik LE, Sexton KA, Bernstein MT, Walker JR, Graff LA.

Gastroenterology. 2015 Nov;149(6):1634. doi: 10.1053/j.gastro.2015.09.025. Epub 2015 Oct 1. No abstract available.

PMID:
26428466
43.

Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research.

Targownik LE, Suissa S.

Am J Gastroenterol. 2015 Dec;110(12):1647-50. doi: 10.1038/ajg.2015.210. Epub 2015 Sep 1.

PMID:
26323186
44.

Cesarean Section Delivery Is Not a Risk Factor for Development of Inflammatory Bowel Disease: A Population-based Analysis.

Bernstein CN, Banerjee A, Targownik LE, Singh H, Ghia JE, Burchill C, Chateau D, Roos LL.

Clin Gastroenterol Hepatol. 2016 Jan;14(1):50-7. doi: 10.1016/j.cgh.2015.08.005. Epub 2015 Aug 8.

PMID:
26264640
45.

The Relationship Among Perceived Stress, Symptoms, and Inflammation in Persons With Inflammatory Bowel Disease.

Targownik LE, Sexton KA, Bernstein MT, Beatie B, Sargent M, Walker JR, Graff LA.

Am J Gastroenterol. 2015 Jul;110(7):1001-12; quiz 1013. doi: 10.1038/ajg.2015.147. Epub 2015 Jun 16.

PMID:
26077178
46.

Characterization of inflammatory bowel disease in elderly patients: A review of epidemiology, current practices and outcomes of current management strategies.

Stepaniuk P, Bernstein CN, Targownik LE, Singh H.

Can J Gastroenterol Hepatol. 2015 Aug-Sep;29(6):327-33. Epub 2015 Jun 12. Review.

47.

Patterns and Predictors of Long-term Nonuse of Medical Therapy Among Persons with Inflammatory Bowel Disease.

Melesse DY, Targownik LE, Singh H, Blanchard JF, Bernstein CN.

Inflamm Bowel Dis. 2015 Jul;21(7):1615-22. doi: 10.1097/MIB.0000000000000418.

PMID:
25970546
48.

Health Care Use by a Population-Based Cohort of Children With Inflammatory Bowel Disease.

Singh H, Nugent Z, Targownik LE, El-Matary W, Brownell M, Bernstein CN.

Clin Gastroenterol Hepatol. 2015 Jul;13(7):1302-1309.e3. doi: 10.1016/j.cgh.2015.01.022. Epub 2015 Jan 28.

PMID:
25638585
49.

Academic Performance among Children with Inflammatory Bowel Disease: A Population-Based Study.

Singh H, Nugent Z, Brownell M, Targownik LE, Roos LL, Bernstein CN.

J Pediatr. 2015 May;166(5):1128-33. doi: 10.1016/j.jpeds.2014.12.010. Epub 2015 Jan 15.

PMID:
25598305
50.

Immortal time bias: a likely alternate explanation for the purported benefits of DXA Screening in ulcerative colitis.

Targownik LE.

Am J Gastroenterol. 2014 Oct;109(10):1689. doi: 10.1038/ajg.2014.234. No abstract available.

PMID:
25287099

Supplemental Content

Loading ...
Support Center